oncology commercialization & market access conference preview
DESCRIPTION
Preview of 9th Annual Oncology Commercialization & Market Access Conference (March 22-23, 2016; San Francisco, CA)TRANSCRIPT
Commercialization & Market AccessN C O L O G Y
March 22-23, 2016 • San Francisco, CA
Determine Cost Value Differentiation to Enable Market Access and Product Uptake
9TH ANNUAL
Previous Attendee Acclaim:
“Excellent overview of the oncology commercialization process and very encompassing in its coverage of key elements.”
— Director, Clinical Services, Town Total Health
“Very good, practical discussion.”— Anonymous
TOP REASONS TO ATTEND:
• Identify the pros and cons of building a commercial strategy vs. partnering with an established commercial organization for your product
• Explore emerging trends on oncology payment reforms
• Build a product value story to increase market access and accelerate product uptake
• Discuss the role of cost vs. value for oncology and combination therapies
• Identify strategies for working with payers and manufacturers to position therapies on product formularies
• Measure and manage immune-mediated toxicity to ensure access and product uptake
• Implement successful therapeutic drug monitoring processes into your organization
CBI, a division ofUBM Life Sciences
WWW. C B I N E T . C O M
With Oncology therapies representing an extensive portion of bio/pharmaceutical pipelines, they continue to be one of the key growth areas for the industry today. In order to remain on the forefront of this very competitive space, it is critical for companies to begin reaching commercialization and attain competitive market access in this high-risk and high-reward arena.
WHO SHOULD ATTENDThis event will benefit executive or senior-level directors and their teams from the oncology pharmaceutical or biotech industries with responsibilities or involvement in the following areas:
Commercialization
Commercial Operations
Oncology/Therapeutic Lead Development
National Accounts/Account Management
Market Access
Pricing and Contracts
Payer Strategy
Reimbursement and Access
HEOR
This conference will also benefit specialty pharmacies and distributors, reimbursement and market access consultants and oncology marketing and commercialization solutions providers.
*This is preliminary conference information. Topics, agenda and speaker names are subject to change without notice.
C O N F E R E N C E P R E V I E W *
For sponsorship opportunites, contact Taylor Biggers at 339-298-2108 or email [email protected].
CONFERENCE SPONSOR: